| Title： | Diagnosis, treatment and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement (Fourth Edition) |
| Edition： | Updated |
| Classification： | Experts consensus |
| Field： | Comprehensive guideline |
| Countries and regions： | China |
| Guidelines users： | Specialized medical personnel who may contact with children with 2019-nCoV infection |
| Evidence classification method： | experts consensus |
| Development unit： | China Medicine Education Association Committee on Pediatrics Cooperative Group of Ashma, the Subspecialty Group of Respiratory, the Society of Pediatrics, Chinese Medical Association Chinese Medical Doctor Association Committee on Respirology Pediatrics Chinese Research Hospital Association Committee on Pediatrics Chinese Non-Government Medical Institutions Association Committee on Pediatrics China Association of Traditional Chinese Medicine, Committee on Children’s Health and Medicine Research China News of Drug Information Association, Committee on Children’s Safety Medication Global Pediatric Pulmonology Alliance |
| Registration time: | 2022-04-30 |
| Registration number： | IPGRP-2022CN251 |
| Purpose of the guideline: | In order to guide the treatment of children's 2019-nCoV infection with the times, with reference to the "Diagnosis and Treatment Plan for 2019 novel coronavirus pneumonia (Trial Ninth Edition)" issued by the National Health Commission, "Diagnosis, treatment and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement (Third Edition)" , and pediatric-related viral infection diagnosis and treatment strategies, the " Diagnosis, treatment and prevention of 2019 novel coronavirus infection in children: experts’ consensus statement (Fourth Edition)" is specially formulated for clinical reference |
